Expecting gross proceeds of $10M, CEL-SCI Corp. (CVM -10.6%) prices its best efforts public offering at $1.40/unit. Each unit consists of one share of common stock plus 0.25 warrant to purchase one share of common. The warrants expire on October 17, 2014 and are immediately exercisable at $1.58.
Closing date is April 17.
Proceeds to fund its Phase 3 clinical trial, R&D and general corporate purposes.